[Restrictive cardiomyopathy]

Area of Science:

• Cardiology
• Cardiovascular Medicine
• Internal Medicine

Context:

• Restrictive cardiomyopathies are the rarest form of cardiomyopathy, characterized by impaired ventricular filling and reduced diastolic volume.
• These conditions may be idiopathic, familial, or secondary to other diseases like amyloidosis or hypereosinophilic syndrome.
• Clinical presentation often mimics other cardiac conditions, complicating diagnosis.

Purpose:

• To review the characteristics, diagnostic challenges, and management strategies for restrictive cardiomyopathies.
• To highlight the differential diagnosis between restrictive cardiomyopathy and constrictive pericarditis.
• To discuss current and emerging therapeutic approaches, particularly for amyloidosis-associated restrictive cardiomyopathy.

Summary:

• Restrictive cardiomyopathy presents with diastolic dysfunction, normal ventricular wall thickness, and preserved systolic function, often with increased interstitial fibrosis.
• Symptoms include signs of heart failure (except cardiomegaly), thromboembolic events, atrial fibrillation, and atrioventricular block.
• Diagnostic modalities include echocardiography, MRI, CT, and biopsy; treatment involves diuretics, anticoagulants, and management of arrhythmias, with cardiac transplantation as an option for advanced cases.

Impact:

• Improved understanding of restrictive cardiomyopathies aids in earlier diagnosis and more effective patient management.
• Highlights the importance of differentiating from constrictive pericarditis for appropriate treatment selection.
• Emphasizes the need for targeted therapies, especially for specific etiologies like cardiac amyloidosis.